Atomo Diagnostics managing director John Kelly said news of Ellume’s successes “helps the sector in general and provides more confidence”.Atomo generates the majority of its business offshore, with a flagship product which is a self-HIV test, as well as TGA-approved COVID-19 tests. Mr Kelly said while there was traction growing in the diagnostics space, home-grown businesses had to be well-funded and globally-focused to succeed.“You’ve got to be well capitalised and the Australian market is limited by its size. If you want to get beyond a certain size, you have to head overseas.”Mr Lanyon agreed, saying Ellume's success came after securing significant funding both overseas and in Australia, where the Queensland government committed $50 million to support the manufacturing effort."It takes a lot of investment to do this - and the more capital available, the better." From an article Dec 17th
- Forums
- ASX - By Stock
- AT1 FY21 - General Discussion + FA
-
-
- There are more pages in this discussion • 1,722 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AT1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $12.14M |
Open | High | Low | Value | Volume |
2.0¢ | 2.0¢ | 1.9¢ | $4.355K | 222.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 1968855 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 416397 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 1968855 | 0.019 |
4 | 486664 | 0.018 |
1 | 60000 | 0.016 |
3 | 366662 | 0.015 |
1 | 36000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 416397 | 3 |
0.021 | 32000 | 1 |
0.022 | 40000 | 1 |
0.023 | 200000 | 1 |
0.024 | 126743 | 3 |
Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |